MRVI

Maravai LifeSciences Holdings Inc

Feb 27 • 04:00PM ET

3.56

0.00 0.00 %

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN BIO RGEN BMRN BIOX ACRS ALDX APLS

| Held by: VTI IWM VXF IWN IBB SCHA VTWO VHT DFAS PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.91	Insider Own	28.83%	Shs Outstand	145.02M	Perf Week	14.84%
Market Cap	910.32M	Forward P/E	-	EPS next Y	-0.14	Insider Trans	0.77%	Shs Float	103.21M	Perf Month	4.09%
Enterprise Value	1.22B	PEG	-	EPS next Q	-0.05	Inst Own	77.30%	Short Float	10.61%	Perf Quarter	-5.32%
Income	-130.77M	P/S	4.90	EPS this Y	37.28%	Inst Trans	-1.74%	Short Ratio	9.35	Perf Half Y	52.79%
Sales	185.74M	P/B	2.10	EPS next Y	24.90%	ROA	-11.40%	Short Interest	10.95M	Perf YTD	9.54%
Book/sh	1.70	P/C	3.74	EPS next 5Y	24.47%	ROE	-41.06%	52W High	4.11 -13.28%	Perf Year	16.72%
Cash/sh	0.95	P/FCF	-	EPS past 3/5Y	- -	ROIC	-21.84%	52W Low	1.66 113.81%	Perf 3Y	-75.36%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-40.53% -8.15%	Gross Margin	17.33%	Volatility	5.08% 5.50%	Perf 5Y	-89.05%
Dividend TTM	-	EV/Sales	6.57	EPS Y/Y TTM	12.14%	Oper. Margin	-50.34%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.56	Sales Y/Y TTM	-28.34%	Profit Margin	-70.41%	RSI (14)	61.98	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.29	EPS Q/Q	-33.41%	SMA20	12.18%	Beta	0.38	Target Price	4.33
Payout	-	Debt/Eq	1.50	Sales Q/Q	-11.59%	SMA50	3.27%	Rel Volume	1.15	Prev Close	3.56
Employees	570	LT Debt/Eq	1.44	Earnings	Feb 25 AMC	SMA200	21.31%	Avg Volume	1.17M	Price	3.56
IPO	Nov 20, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.02% 1.67%	Trades		Volume	1,352,109	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral	$9 → $3
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell	$4.25
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$10
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$11 → $10
Apr-10-24	Initiated	Craig Hallum	Buy	$15
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$10 → $8
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral	$18 → $14
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral	$20 → $16
Dec-14-22	Initiated	Deutsche Bank	Buy	$25
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$22
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral	$32 → $17
Aug-25-22	Initiated	Credit Suisse	Outperform	$34
Aug-05-21	Resumed	Credit Suisse	Outperform	$44
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight	$33
Dec-15-20	Initiated	William Blair	Outperform

Show Previous Ratings

Feb-26-26 08:30AM	Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call Summary (Moby) +9.20%
02:11AM	Maravai LifeSciences Q4 Earnings Call Highlights (MarketBeat)
Feb-25-26 07:25PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:01PM	Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-09-26 05:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 (Business Wire)
08:00AM	Loading…
Nov-10-25 08:00AM	Maravai LifeSciences Announces November 2025 Investor Conference Schedule (Business Wire) +8.01%
Nov-07-25 12:12AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-06-25 06:15PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Maravai LifeSciences Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-04-25 09:05AM	AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates (Zacks)
Oct-22-25 04:01PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 (Business Wire)
Aug-12-25 03:07AM	Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com) +30.58%
Aug-11-25 07:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -6.36%
04:05PM	Maravai LifeSciences Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-28-25 05:08PM	Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 (GlobeNewswire) -6.42%
04:01PM	Loading…
Jun-25-25 04:01PM	Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer (GlobeNewswire)
Jun-09-25 08:30AM	Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors (GlobeNewswire)
Jun-03-25 10:00AM	TriLink BioTechnologies and Quantoom Biosciences Sign License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
May-21-25 04:22PM	CORRECTION - Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire) -6.25%
04:05PM	Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire)
May-20-25 08:00AM	TriLink BioTechnologies debuts its first mRNA synthesis kit with CleanCap capping technology; Celebrates launch with kit donations to top academic institutions (Business Wire) +10.60%
May-14-25 04:00PM	TriLink BioTechnologies and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines (Business Wire)
May-13-25 09:30AM	Q1 2025 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:11AM	Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ... (GuruFocus.com)
May-12-25 05:20PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.07%
04:06PM	Maravai Lifesciences Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 05:10PM	Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-07-25 07:10PM	MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-05-25 05:47AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
May-01-25 05:20PM	Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:30AM	Loading…
07:30AM	Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 (GlobeNewswire)
Apr-24-25 12:27PM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Apr-22-25 05:45AM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI (PR Newswire) +9.04%
Apr-16-25 06:10PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-15-25 09:35AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-14-25 01:13PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-11-25 01:31PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-10-25 11:34AM	QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains? (Zacks) -8.25%
04:37AM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman (Newsfile)
Apr-04-25 02:34PM	Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive (Seeking Alpha) -7.62%
Apr-03-25 06:21PM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-01-25 01:23PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 12:49PM	Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management? (InsiderMonkey)
Mar-24-25 02:33PM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-22-25 10:30AM	Maravai Lifesciences price target lowered to $5 from $10 at Stifel (TipRanks)
Mar-21-25 08:00PM	Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript (Motley Fool) -5.62%
01:43PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-20-25 09:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript (SeekingAlpha)
Mar-18-25 04:05PM	Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) -5.81%
05:45AM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRVI (PR Newswire)
Mar-17-25 02:22AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire) +7.76%
Mar-16-25 09:32AM	3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk (Motley Fool)
Mar-08-25 10:15AM	Maravai LifeSciences Holdings, Inc. (MRVI): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? (Insider Monkey)
Feb-28-25 09:31AM	Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman (PR Newswire) +5.57%
Feb-27-25 06:37PM	Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development (Insider Monkey) -6.15%
Feb-25-25 06:00AM	Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (GlobeNewswire) -21.70%
Feb-24-25 08:00AM	Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio (Business Wire)
Feb-04-25 04:01PM	TriLink BioTechnologies and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Feb-03-25 06:00AM	TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in Europe (Business Wire)
Jan-28-25 04:01PM	Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies (Business Wire) -8.55%
Jan-20-25 11:02PM	Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-08-25 04:10PM	Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue (GlobeNewswire) -20.88%
Dec-20-24 07:15AM	Maravai Lifesciences initiated with a Neutral at Guggenheim (TipRanks)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire) -6.00%
Nov-12-24 08:05AM	Maravai LifeSciences Announces November 2024 Investor Conference Schedule (GlobeNewswire)
Nov-09-24 06:51AM	Maravai Lifesciences price target lowered to $9 from $10 at Baird (TipRanks)
Nov-08-24 02:20PM	Q3 2024 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -35.27%
03:15AM	Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript (Motley Fool)
02:34AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 04:01PM	Maravai LifeSciences Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research (Business Wire)
Oct-15-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:03AM	RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter (Insider Monkey)
Sep-24-24 08:12AM	TriLink BioTechnologies & Alphazyme Collaborate to Launch New CleanScribe RNA Polymerase (Business Wire)
Aug-28-24 07:49AM	Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch AccuRes Host Cell DNA Quantification Kits (Business Wire)
Aug-12-24 08:05AM	Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule (GlobeNewswire)
Aug-08-24 12:45AM	Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript (Motley Fool) -6.87%
Aug-07-24 04:05PM	Maravai LifeSciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Maravai LifeSciences Appoints Trey Martin to Board of Directors (GlobeNewswire)
Jul-10-24 08:00AM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 (GlobeNewswire)
Jul-02-24 04:00PM	Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Jun-20-24 09:15AM	Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics (ACCESSWIRE)
Jun-17-24 09:54AM	Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best (Insider Monkey)
Jun-12-24 02:38AM	Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc (GuruFocus.com)
May-17-24 11:52AM	Maravai (MRVI) Advances in RNA Research With New Collaboration (Zacks)
May-13-24 08:00AM	TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center (Business Wire)
May-09-24 04:18PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript (Insider Monkey) +11.16% +6.09%
04:05PM	Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule (GlobeNewswire)
10:53AM	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating (MT Newswires)
10:11AM	Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating (MT Newswires)
04:02AM	Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
03:15AM	Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript (Motley Fool)
May-08-24 08:57PM	MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Maravai LifeSciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-30-24 07:31AM	TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Apr-18-24 07:36AM	TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production (Business Wire)
Apr-10-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 (GlobeNewswire)
Mar-28-24 04:00PM	Dyadic Reports 2023 Full Year Results and Recent Company Progress (GlobeNewswire)
Mar-19-24 07:48AM	Should You Sell Maravai LifeSciences (MRVI)? (Insider Monkey)

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PRAHALAD MURALI	Former Director	Dec 23 '25	Proposed Sale	3.33	3,951	13,138		Dec 23 03:00 PM
Hopfield Jessica	Former Director	Dec 19 '25	Proposed Sale	3.48	53,951	187,526		Dec 19 04:38 PM
LUCIER GREGORY T	Director	Dec 05 '25	Buy	3.70	51,472	190,446	106,595	Dec 09 04:36 PM
LUCIER GREGORY T	Director	Dec 08 '25	Buy	3.67	48,528	178,098	155,123	Dec 09 04:36 PM
Brust Bernd	Chief Executive Officer	Nov 13 '25	Buy	3.25	216,212	702,689	466,771	Nov 17 04:48 PM
Brust Bernd	Chief Executive Officer	Nov 11 '25	Buy	3.24	157,201	509,331	157,201	Nov 13 05:27 PM
Brust Bernd	Chief Executive Officer	Nov 12 '25	Buy	3.21	93,358	299,679	250,559	Nov 13 05:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRVI

Maravai LifeSciences Holdings Inc

Upgrade your FINVIZ experience